J. J. Finkelstein - President and CEO, Director at REGENERX BIOPHARMACEUTICALS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Issuer Symbol
RGRX on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by J. J. Finkelstein since 14 Mar 2025

Holdings reported by J. J. Finkelstein for REGENERX BIOPHARMACEUTICALS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,712,991 17 May 2022 Direct
Stock Option (Right to Buy) 600,000 17 May 2022 Direct Common Stock 500,000
Convertible Promissory Note (right to buy) 20,880 17 May 2022 Direct Common Stock 27,840
Common Stock Warrant (right to buy) 0 17 May 2022 Direct Common Stock 20,880
Series A Common Stock Warrant (right to buy) 0 17 May 2022 Direct Common Stock 56,250
Series B Common Stock Warrant (right to buy) 0 17 May 2022 Direct Common Stock 56,250

Transactions reported by J. J. Finkelstein for REGENERX BIOPHARMACEUTICALS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.